JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M312838200 on January 29, 2004

J. Biol. Chem., Vol. 279, Issue 16, 16295-16300, April 16, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/16/16295    most recent
M312838200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, A.-Q.
Right arrow Articles by Suchy, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, A.-Q.
Right arrow Articles by Suchy, F. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Association of the 16-kDa Subunit c of Vacuolar Proton Pump with the Ileal Na+-dependent Bile Acid Transporter

PROTEIN-PROTEIN INTERACTION AND INTRACELLULAR TRAFFICKING*

An-Qiang Sun{ddagger}§, Natarajan Balasubramaniyan{ddagger}, Chuan-Ju Liu¶, Mohammad Shahid{ddagger}, and Frederick J. Suchy{ddagger}

From the {ddagger}Department of Pediatrics, Mount Sinai School of Medicine, New York, New York 10029 and the Department of Orthopaedic Surgery, New York University, New York, New York 10003

Received for publication, November 24, 2003 , and in revised form, January 14, 2004.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The rat ileal apical sodium-dependent bile acid transporter (Asbt) transports conjugated bile acids in a Na+-dependent fashion and localizes specifically to the apical surface of ileal enterocytes. The mechanisms that target organic anion transporters to different domains of the ileal enterocyte plasma membrane have not been well defined. Previous studies (Sung, A.-Q., Arresa, M. A., Zeng, L., Swaby, I'K., Zhou, M. M., and Suchy, F. J. (2001) J. Biol. Chem. 276, 6825–6833) from our laboratory demonstrated that rat Asbt follows an apical sorting pathway that is brefeldin A-sensitive and insensitive to protein glycosylation, monensin treatment, and low temperature shift. Furthermore, a 14-mer signal sequence that adopts a {beta}-turn conformation is required for apical localization of rat Asbt. In this study, a vacuolar proton pump subunit (VPP-c, the 16-kDa subunit c of vacuolar H+-ATPase) has been identified as an interacting partner of Asbt by a bacterial two-hybrid screen. A direct protein-protein interaction between Asbt and VPP-c was confirmed in an in vitro pull-down assay and in an in vivo mammalian two-hybrid analysis. Indirect immunofluorescence confocal microscopy demonstrated that the Asbt and VPP-c colocalized in transfected COS-7 and MDCK cells. Moreover, bafilomycin A1 (a specific inhibitor of VPP) interrupted the colocalization of Asbt and VPP-c. A taurocholate influx assay and membrane biotinylation analysis showed that treatment with bafilomycin A1 resulted in a significant decrease in bile acid transport activity and the apical membrane localization of Asbt in transfected cells. Thus, these results suggest that the apical membrane localization of Asbt is mediated in part by the vacuolar proton pump associated apical sorting machinery.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Bile acids are essential for the solubilization and transport of dietary lipids and lipid-soluble nutrients and are the major products of cholesterol catabolism. Maintenance of a sufficient concentration of bile salt molecules in the enterohepatic circulation depends upon high affinity transport systems in the liver, intestine, and kidney. Bile acid transporters belong to large gene families and have been found to mediate the uptake and secretion of cholephilic compounds, contribute to cholesterol homeostasis, and be involved in bile formation. In the past decade, many of these proteins have been cloned and characterized from the liver, blood-brain barrier, placenta, kidneys, and intestine. Interruption of the enterohepatic circulation of bile acids or malfunctioning of these transporters may result in impaired bile formation and fat malabsorption.

During the past decade, the regulation of bile acid transporters has been extensively studied at the transcriptional level (1). By contrast, the mechanisms underlying post-translational regulation and polarized expression of bile acid transporters on the plasma membranes of the intestine and kidney cells have not been fully defined. The rat apical sodium-dependent bile acid transporter (Asbt)1 is located on the apical surface of ileal enterocytes and kidney cells and plays a major role in the recovery of bile acids in a Na+-dependent fashion (2). Mutations in the Asbt gene are associated with bile acid malabsorption in human (3). Little is known about proteins that interact with and regulate trafficking of bile acid transporters.

In this study, we provide the first evidence that the 16-kDa subunit c of the vacuolar proton pump (rat VPP-c, the 16-kDa subunit c of vacuolar H+-ATPase, GenBankTM accession number NM_009729 [GenBank] ) directly interacts with Asbt and contributes to Asbt apical membrane localization. The subunit c is a highly hydrophobic proteolipid with four putative transmembrane helices and assembles into a 260-kDa Vo complex of the vacuolar proton pump (4). Our result suggests an important new role for the subunit c of VPP in protein trafficking.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Plasmid Construction and Clones—The BacterioMatch two-hybrid (B2H) vector, the BacterioMatchTM two-hybrid system (Stratagene), was used for cDNA library screening to search for protein-protein interactions. Fragments encoding the full coding sequence of rat Asbt were cloned into the pBT vector of the B2H system. The full coding sequence of the identified binding proteins (i.e. the 16-kDa subunit c of vacuolar proton pump) was cloned in-frame into the SalI/NotI sites of the pTRG vector to generate the plasmid pTRG-binding protein (pTRG-VPP-c).

Mammalian Cell Expression Vectors—Wild type rat Asbt cDNAs were subcloned into the mammalian expression vector pCMV2 at the Hind III/SalI sites as described previously (5, 6). For the mammalian two-hybrid (M2H) system, pBIND and pACT (Promega) are fusion vectors for the linkage of proteins to the Gal4 DNA binding domain and to the VP16 transactivation domain, respectively. The segment encoding the COOH terminus of rat Asbt (amino acids 308–348) or the full coding sequence of rat Asbt was amplified by PCR and cloned in-frame into the SalI/NotI sites of pBIND fusion vector to produce the plasmid pBIND-Asbt tail and pBIND-Asbt. A complete coding sequence of the identified binding protein (VPP-c) cDNA was inserted in-frame into the SalI/NotI sites of the pACT fusion vector to produce the plasmid construct pACT-VPP-c. A cDNA fragment encoding VPP-c was also inserted in-frame into the BamHI/EcoRI sites of pcDNA3.1/Myc-His (+)A vector to produce the Myc-His-epitope-tagged construct, VPP-c-MH.

The bacterial expression vector pGEX-3X (Invitrogen) was used to produce glutathione S-transferase (GST)-fused recombinant proteins in Escherichia coli. The full coding sequence of VPP-c was subcloned in-frame into the BamHI/EcoRI sites of pGEX-3X to produce the GST-fused plasmid constructs. All of the positive clones containing cDNA inserts were identified by restriction enzyme mapping and sequenced using the ABI automated DNA sequencer model 377 at the DNA Core Facility, Mount Sinai School of Medicine.

BacterioMatch Two-hybrid System XR Plasmid cDNA Library Screen and Protein-Protein Interaction Assay—A library screen based on the B2H system was performed to identify proteins that interact with rat Asbt. In this study, the mouse kidney BacterioMatchTM two-hybrid system XR cDNA library in the pTRG plasmid (Stratagene) was screened with the constructed pBT-Asbt using the protocol provided by the manufacturer with some modification. Briefly, pBT-Asbt and pTRG-cDNA library plasmids were first introduced into B2H reporter strain, and transformants were selected on LB-CTCK plates (LB-agar plates supplemented with 250 µg/ml carbenicillin, 15 µg/ml tetracycline, 34 µg/ml chloramphenicol, and 50 µg/ml kanamycin). Then, the selected colonies were screened for {beta}-galactosidase activity by growth on X-gal indicator plates (LB-agar plates supplemented with 15 µg/ml tetracycline, 34 µg/ml chloramphenicol, 50 µg/ml kanamycin, 80 µg/ml X-gal, and 0.2 mM {beta}-galactosidase inhibitor (phenylethyl {beta}-D-thiogalactoside)) for 17–30 h at 30 °C. To confirm the detected protein-protein interactions, we then retransformed the reporter strain with the isolated target plasmid plus bait plasmid as described by the manufacturer.

In Vitro Binding Assay (GST Pull Down)—For expression of the GST fusion proteins, the appropriate plasmids (GST-VPP-c, see above for coordinates) were transformed into E. coli DH5{alpha} (Invitrogen). The fusion proteins were affinity-purified on glutathione-agarose beads as described by Liu et al. (7). Briefly, GST fusion proteins were expressed in E. coli DH5{alpha} cells and induced by the addition of 0.5~2mM isopropyl-{beta}-D-thiogalactopyranoside. The harvested bacteria were homogenized in extraction buffer (phosphate-buffered saline (PBS) containing 1% Triton X-100, 5 µg/ml leupeptin, 5 µg/ml pepstatin) and centrifuged to remove the insoluble proteins and cell debris right after the extraction process. The extracts were mixed with 200 µl of glutathione-Sepharose 4B (Amersham Biosciences) for 5 min. The Sepharose beads were washed with extraction buffer and used for the GST pull-down assay or GST affinity chromatography. The purity of the fusion proteins was verified by Coomassie Blue staining of SDS-PAGE, and the concentration was determined by a protein assay kit (Bio-Rad). To examine the binding of VPP-c with rat Asbt in vitro, the GST pull-down experiments were performed by using ProFoundTM pull-down GST protein:protein interaction kit (Pierce) as described by the manufacturer. The bound proteins were denatured in sample buffer and separated by 12% SDS-PAGE and were detected by immunoblotting with anti-Asbt antibodies as described previously (5).

Mammalian Two-hybrid Assay for Proteins Interaction in Vivo— When cell cultures reached about 50% confluence, COS-7 cells were cotransfected with 1 µg each of the pBIND-Asbt and pACT-VPP plasmids using Lipofectin (Invitrogen) according to the manufacturer's recommendations. Plasmid pUC19 was used as a carrier to bring the total amount of DNA in the transfection solution to 3 µg. The cultures were harvested 48 h after transfection and lysed. The firefly luciferase activity was determined according to manufacturer's recommendations.

Cell Culture and Chemical Treatments—COS-7 (SV40 transformed monkey kidney fibroblast) and MDCK II (Madin-Darby canine kidney) cells were used in this study. The plasmid pCMV2-Asbt was used to transiently transfect COS-7 for the GST pull-down assay. pBIND-Asbt and pACT-VPP-c were used to transiently cotransfect COS-7 for M2H. The MDCK II cells were stably cotransfected with pCMV2-Asbt and VPP-c-MH plasmids for confocal microscopy analysis. Cell culture and DNA transfection of cells were performed as described previously (5). For bafilomycin A1 (BA1) treatment, the cotransfected cells were incubated with 50 nM bafilomycin A1 (Sigma) in culture medium for 16 h at 37 °C.

Indirect immunofluorescence microscopy was carried out as described previously (5). Briefly, indirect immunofluorescence microscopy was performed on a confluent monolayer of transfected cells cultured on glass coverslips. The cells were fixed and permeabilized for 7 min in methanol at -20 °C, followed by rehydration in PBS. Nonspecific sites were blocked with normal goat serum for 60 min at room temperature. The primary antibody was diluted in the blocking buffer (1% bovine serum albumin in PBS, 0.2% Triton X-100) and incubated for 2 h at room temperature in a humid chamber. After washing with PBS for 15–30 min, the cells were incubated with secondary antibodies conjugated to fluorescein isothiocyanate or Texas Red for 1 h. After being washed with PBS, the cells on coverslips were inverted onto a drop of VectaShield. Fluorescence was examined with a Leica TCS-SP (UV) four-channel confocal laser scanning microscope in the Imaging Core Facility Microscopy Center at the Mount Sinai School of Medicine. A rabbit polyclonal antibody against the COOH-terminal 14 amino acid of rat Asbt and mouse anti-Myc antibodies was used for this study as described previously (5, 6).

Bile Acid Influx Assay—Na+-dependent taurocholate influx assays were performed as described previously using a transwell filter culture system (5).

Domain-selected biotinylation was performed essentially as described by Lisanti et al. (8) and Altin et al. (9). Briefly, polarized monolayers of transfected cells grown on 24-mm transwell filters were washed with ice-cold PBS containing 1 mM MgCl2 and 0.1 mM CaCl2 (PBS-C/M). Sulfo-NHS-LC-biotin (Pierce) (0.5 mg/ml in PBS-C/M, pH 8.5) was added either to the apical or basolateral compartment of the filter chamber. Compartments not receiving sulfo-NHS-LC-biotin were filled with an equivalent volume of PBS-C/M alone. After 30 min of incubation at 37 °C, filter chambers were washed with ice-cold PBS-C/M. Three filter chambers were used for each experimental condition. After extraction with 1% SDS, the biotinylated transporters were analyzed by SDS-PAGE.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Identification of Asbt-associated Proteins by BacterioMatch Two-hybrid Library Screening—A cDNA library screening based on the BacterioMatch two-hybrid system was used to identify proteins that interact with rat Asbt. For this purpose, the rat Asbt coding sequence was subcloned into plasmid pBT (pBT-Asbt) to serve as bait. A mouse kidney BacterioMatch two-hybrid system XR cDNA library in the pTRG plasmid was screened with the constructed pBT-Asbt. We screened about 2.5 million clones and identified more than 50 positive clones grown on LB-CTCK agar plates. These positive clones were then tested on X-gal indicator plates, and 18 of them showed increased {beta}-galactosidase activity (data not show), indicating a possible protein-protein interaction. After isolation and purification of the selected clones, the plasma DNAs were sequenced. The DNA sequence analysis revealed that the clone number 13 (pTRG-13) matched the full sequence encoding the mouse 16-kDa subunit c of the vacuolar proton pump. The amino acid sequence of mouse VPP subunit c is identical to the sequence of the rat protein (GenBankTM accession number NM_130823 [GenBank] ) (10).

To further verify the interaction between Asbt and VPP-c from the library screening, the mouse/rat VPP subunit c coding sequence was subcloned into pTRG plasmid (pTRG-VPP-c). The purified pBT-Asbt and pTRG-VPP-c constructs were cotransformed into the bacterial reporter strain and tested on LB-CTCK and X-gal indicator plates. All transformants (coexpression of VPP-c and Asbt) grew well on the LB-CTCK plate (Fig. 1, left panel) and had strong {beta}-galactosidase activity (blue) on the X-gal indicator plates (Fig. 1, right panel). The negative control (pBT-GF2/pTRG-vector) showed no {beta}-galactosidase activity (white).



View larger version (37K):
[in this window]
[in a new window]
  		FIG. 1.
Protein-protein interaction of rat Asbt and VPP-c. Each pair of plasmids, as indicated, in the vector pBT (i.e. pBT-Asbt and pBT-GF2) and the vector pTRG (i.e. pTRG-VPP-c, pTRG-Gal11P, and pTRG vector alone) was cotransformed into bacterial reporter strains. The known interaction between GF2 and Gal11P is used as a positive control, whereas the lack of interaction of GF2 and pTRG vector serves as a negative control. Left panel, retransformation of the reporter strain with isolated pBT-Asbt and pTRG-VPP-c. Bacterial transformants were grown on LB-CTCK plates (see "Materials and Methods"). Right panel, the specificity of protein-protein interactions was confirmed using the {beta}-galactosidase reporter. Bacterial transformants were selected on an X-gal indicator plate.

 
Interaction between Asbt and VPP-c in Vitro (GST Pull-down Assay)—An in vitro interaction between Asbt and VPP-c was verified using the GST pull-down assay. First, the cDNA coding sequence of VPP-c was subcloned into pGEX3X vector to generate a GST-fused VPP-c (GST-VPP-c), and the fusion protein was expressed in the DH5{alpha} bacterial strain. Affinity-purified GST and GST-VPP-c immobilized to the glutathione-Sepharose beads were incubated with lysates of Asbt expressing COS-7 cells. The bound proteins eluted from the beads were separated by SDS-PAGE and electroblotted onto nitrocellulose membrane. The proteins were then detected using a specific rat Asbt COOH-terminal anti-peptide antibody. Fig. 2 shows that purified GST did not pull down Asbt in this assay (A, lane 4), whereas GST-VPP-c efficiently pulled down a non-glycosylated Asbt protein (A, lane 3, ~34 kDa). To further verify the possibility of direct interaction of Asbt with VPP-c, the bound proteins from GST pull-down experiments were denatured in sample buffer, separated by 12% SDS-PAGE, and detected by Coomassie Blue staining. The results show that a single protein (a ~34-kDa band) was pulled down by GST-VPP-c (Fig. 2B, lane 2), but no protein was bound by GST-Sepharose (B, lane 3). This suggests that Asbt interacts with VPP-c directly.



View larger version (48K):
[in this window]
[in a new window]
  		FIG. 2.
Direct interaction between Asbt and VPP-c in vitro (GST pull-down assay). A, purified GST (lane 4) or GST-VPP-c (lane 3) immobilized onto glutathione-Sepharose beads was incubated with cell extracts prepared from COS-7 cells transfected with a plasmid encoding Asbt and was examined by Western blotting with a specific rat Asbt C-terminal anti-peptide antibody. The cell extracts from Asbt transfected COS-7 cells that were treated with tunicamycin to abolish the glycosylation of Asbt or without tunicamycin are shown on lane 2 and lane 1, respectively. Asbt (upper) as well as its non-glycosylated form (lower) are indicated by arrows. B, the bound proteins by GST pull-down experiments were denatured in sample buffer, separated by 12% SDS-PAGE, and detected by Coomassie Blue staining. The results show that a single protein band (~34 kDa) was pulled down by GST-VPP-c (lane 2), but no protein was found by GST pull down (lane 3). Lane 1 shows the protein molecular mass standards.

 
Examination of Protein-Protein Interaction by in Vivo Mammalian Two-hybrid Luciferase Assay—To further confirm the interaction of Asbt and VPP-c in mammalian cells, we performed a mammalian two-hybrid assay in which the expression of the firefly luciferase gene was driven by Gal4-specific enhancer elements. The complete coding sequence of rat Asbt cDNA was inserted in-frame into the SalI/NotI sites of the pBIND fusion vector (pBIND-Asbt). A cDNA fragment encoding the complete coding region of VPP-c was generated by PCR and was inserted in-frame into the SalI/NotI sites of the pACT fusion vector (pACT-VPP-c). The two constructs were cotransfected into COS-7 cells. To examine the importance of the cytoplasmic tail of Asbt in protein binding to VPP-c, a cDNA encoding the 40-amino acid cytoplasmic tail fragment of Asbt was also inserted in-frame into the SalI/NotI sites of the pBIND fusion vector (pBIND-Asbt tail) and cotransfected with pACT-VPP-c into the cells. By analogy to the B2H system, the interaction between Asbt and VPP-c brings together the Gal4D binding domain and the VP16 transactivation domain of the fusion proteins and activates the luciferase reporter gene in COS-7 cells (Fig. 3). Fig. 3 shows that a more than 10-fold increase of luciferase activity was observed in Asbt and VPP-c cotransfected cells compared with non-transfected cells. Therefore, any post-translational modifications that may occur in mammalian cells, but are absent in bacteria, do not interfere with the interaction of Asbt and VPP-c. However, only a slight increase of luciferase activity was observed in cells cotransfected with Asbt-tail and VPP-c cDNAs (Fig. 3).



View larger version (12K):
[in this window]
[in a new window]
  		FIG. 3.
Examination of the interaction between Asbt and VPP-c by a mammalian two-hybrid luciferase assay. The Gal4 DNA recognition sequence in the reporter plasmid drives the expression of the firefly luciferase. A cDNA fragment encoding the 40-amino acid cytoplasmic tail of rat Asbt (pBIND-tail) or the full open reading frame of rat Asbt (pBIND-Asbt) is linked to a sequence encoding Gal4DBD in the vector pBIND. A cDNA fragment encoding the full open reading frame of VPP-c is linked to a sequence encoding the VP16AD in the vector pACT (pACT-VPP). The plasmids, as indicated, were cotransfected into COS-7 cells. After incubation, the firefly luciferase activity was determined in cell lysates. All experiments were performed at least twice with triplicate samples and depicted as means ± S.E.

 
Colocalization of Asbt and VPP-c in Transfected Mammalian Cells—Next, we examined the subcellular localization of Asbt and VPP-c. A Myc-epitope-fused VPP-c (VPP-c-MH) and rat Asbt were cotransfected into COS-7 or MDCK cells. In transfected COS-7 cells, colocalization of Asbt and VPP-c-MH was detected in a punctate cytoplasmic and perinuclear pattern (Fig. 4I, C and D, yellow). Because the flat cells of non-polarized MDCK cells would be better for the visualization of protein colocalization, we selected the flat non-polarized MDCK cells for this study. In transfected MDCK cells, the colocalization of Asbt and VPP-c was observed near the nuclear region (Fig. 4II, C and D, yellow). This is in agreement with the physical interactions detected in the two-hybrid and pull-down assays and suggests that in transfected MDCK cells, the membrane sorting of Asbt may be mediated in part by the VPP-c and through other unknown sorting mechanisms.



View larger version (81K):
[in this window]
[in a new window]
  		FIG. 4.
Cellular colocalization of Asbt and VPP-c in transfected cells by confocal microscopy. I and II, interaction of Asbt and subunit c of vacuolar proton pump (VPP-c) in situ. COS-7 or MDCK cells were cotransfected with rat Asbt and Myc-His-epitopetagged VPP-c plasmids (VPP-c-MH). VPP-c-MH was detected by mouse anti-Myc antibodies and visualized by fluorescein-labeled antimouse IgG (A, green). Asbt was detected by a specific rat Asbt COOH-terminal anti-peptide antibody and visualized by Texas Red-labeled anti-rabbit IgG (B, red). C shows a merged picture, and D shows an enlarged merged picture. The arrows (in D) indicate the colocalization of Asbt and VPP-c (yellow). III and IV, effects of bafilomycin A1 treatment on the cellular distribution of Asbt and VPP-c-MH in transfected COS-7 and MDCK cells. The transfected cells were treated with 50 nM BA1 overnight at 37 °C. The cells were grown on glass coverslips and fixed with cold 100% MtOH after BA1 treatment. Bar = 5 µm.

 
The Effect of Bafilomycin A1 on Membrane Localization of Asbt—To examine a possible role of VPP-c in the cellular trafficking of Asbt, we pretreated the cotransfected cells with 50 nM bafilomycin A1 (BA1), a specific inhibitor of the vacuolar proton pump, for 16 h at 37 °C. The confocal image shows that BA1 treatment significantly interrupted Asbt and VPP-c-MH subcellular distribution and colocalization in both COS-7 (Fig. 4III) and MDCK cells (Fig. 4IV). In contrast to the colocalization of Asbt with VPP-c-MH shown as yellow, the distinct localization of VPP-c-MH and Asbt is seen as separate green and red labels, respectively (Fig. 4, III and IV, D). After treatment with BA1, a diffuse cytoplasmic staining was observed for VPP-c-MH in both COS-7 and MDCK cells (Fig. 4, III and IV, A). In both COS-7 and MDCK cells, a significant increase in the amount of Asbt protein accumulated intracellularly at endoplasmic reticulum and Golgi regions after BA1 treatment (Fig. 4, III and IV, B).

To further verify the effect of BA1 treatment on the membrane distribution of Asbt, the polarized taurocholate influx assay and domain-specific biotinylation experiments were performed in transfected MDCK cells. Fig. 5 (left panel) shows that the initial taurocholate influx activity decreased more than 30% after BA1 treatment compared with that of BA1-untreated MDCK cells. Similarly, biotinylation analysis demonstrated that the apical membrane distribution of Asbt proteins was significantly decreased by about 26.2 ± 4.1% after BA1 treatment compared with that of BA1-untreated MDCK cells (Fig. 5, center and right). Thus, these results indicate further that the VPP-c interacts with Asbt and may contribute, at least partially, to the apical membrane localization of Asbt in epithelial cells.



View larger version (26K):
[in this window]
[in a new window]
  		FIG. 5.
Effects of BA1 treatment on initial transport activity and polarized membrane distribution of rat Asbt in stably transfected MDCK cells. The cotransfected cells were pretreated with (+) or without (-) 50 nM bafilomycin A1 for 16 h at 37 °C. Left, MDCK cells cotransfected with Asbt and VPP-c-MH plasmid DNA were grown on 6-mm permeable transwell filter inserts for 5 days to ensure a polarized phenotype. The effects of BA1 treatment on the polarity of the Na+-dependent taurocholate uptake were measured by incubating cells in 10 µM [3H]taurocholate at 37 °C for 10 min. Center, domain-specific biotinylation. Transfected MDCK cells were grown on 24-mm permeable transwell filter inserts for 5–7 days. Sulfo-NHS-LC-biotin was added either to the apical or basolateral compartment of the filter chamber. Compartments not receiving sulfo-NHS-LC-biotin were filled with an equivalent volume of PBS-C/M alone. After extraction with 1% SDS, the biotinylated Asbt was analyzed by Western blotting. The Asbt was detected by a specific rat Asbt C-terminal anti-peptide antibody (upper panel). The protein concentration was normalized to the amount of actin protein detected by an anti-actin antibody (lower panel). Right, densitometric analyses of membrane distribution of rat Asbt with or without BA1 treatment (n = 2). All experiments were performed at least twice with triplicate samples and depicted as means ± S.E.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The physiologic functions of ion transporters are determined in part by their subcellular distributions and a complex interaction of protein molecules modulating their activities and intracellular trafficking (11). Sorting signal motifs for apical membrane targeting, such as N- and O-glycosylation, the glycosylphosphatidylinositol anchor, and PDZ binding sequence, have been reported (8, 12, 13). Most recent studies demonstrated that a Tyr-based sorting signal motif and {beta}-turn structure are also involved in the apical targeting of Megalin (14) and Asbt (15), respectively. This suggests that the more precise structural features and possibly a tissue-specific regulator may be important as determinants for apical membrane sorting. Over the past decades, studies of various membrane trafficking steps have indicated that specific proteins (e.g. clathrin-coated complex Munc18-2, syntaxin 3, dynein, and PDZ domain-containing proteins) play a role in regulation of apical protein localization (16–20). These factors may be directly or indirectly associated with the sorted proteins and cooperate with each other to generate targeting specificity in the secretory pathway (21). Some membrane proteins (e.g. matrix metalloproteinases) contain multiple sorting signal motifs and are regulated by several sorting factors and sorting mechanisms (22, 23).

The vacuolar H+-ATPases are a family of ATP-dependent proton pumps (VPP) that reside predominantly within intracellular membrane compartments including endosomes, lysosomes, cathrin-coated vesicles, and the Golgi complex (24, 25). The acidic luminal pH within these organelles and vesicles of the secretory pathway is established by vacuolar H+-ATPases and is vital for processes such as intracellular membrane transport, receptor-mediated endocytosis, protein processing and degradation, and intracellular targeting of lysosomal enzymes (24–33). They are multisubunit heteromeric proteins composed of two structural domains, a peripheral catalytic V1 domain and a membrane-spanning Vo domain. The Vo domain is responsible for proton translocation, and the V1 domain is responsible for ATP hydrolysis. All of the subunits of the H+-V-ATPase (VPP) have been now identified and many of their structural and molecular properties characterized (24). The integral Vo domain of the V-ATPase complex composed of five different subunits (a, c, c', c'', and d) mediates proton translocation. Six copies of the c subunit are found in the Vo complex. The 16-kDa subunit c is highly hydrophobic and contains four putative transmembrane helices (4, 33). These subunits appear to remain tightly associated with the Vo domain through protein-protein interaction. Previous studies have demonstrated that VPP is required for proper vesicular trafficking through the trans-Golgi network (34) and/or Golgi to plasma membrane delivery of proteins (35). In both the kidney and reproductive tract, VPP-rich cells have a high rate of apical membrane recycling. VPP molecules are transported between the cell surface and the cytoplasm in vesicles that have a well defined "coat" structure (36). van Weert et al. (34) demonstrated that inhibition of the VPP by bafilomycin A1 induces retrograde transport of proteins from the trans-Golgi network into the Golgi. Palokangas et al. (37) indicated that VPP might be involved with the early secretory pathway and retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex. Interactions between VPP and the microtubule or microfilament-based cytoskeletons have been found in osteoclasis and intercalated cells (33). The Vo domain of V-ATPase appears to have a direct role independent of proton pumping in membrane fusion that is essential for intracellular membrane trafficking along biosynthetic and endocytic routes (33).

Recent studies demonstrate that VPP may directly and/or indirectly interact with other proteins (38). In HepG2 cells, the function of VPP is critical to achieving timely secretion and correct N-linked glycan modifications of proteins that follow the constitutive secretory pathway (35). Geyer et al. (39) demonstrated that existence of a shared domain in three different families of proteins, Subunit H of the VPP, {beta}-adaptins, and {beta}-subunit of COPI. Moreover, Geyer et al. (40) suggest that the H subunit of VPP can function as an adaptor for interactions between Nef and AP-2. Mandic et al. (31) showed that the negative factor from simian immunodeficiency virus binds to the catalytic subunit H of VPP to internalize CD4 and to increase viral infectivity. Miura et al. (41) have shown that the E subunit of VPP by direct interaction with mSos1 may participate in the regulation of the mSos1-dependent Rac1 signaling pathway involved in growth factor receptor-mediated cell growth control. The 16-kDa subunit c of VPP has been reported to interact with several proteins, such as p12I protein (42). The 16-kDa subunit c is also capable of forming gap junctions and binding with {beta}1 integrin independently of ATPase activity (28, 33). The subunit c of VPP may also interact with F-actin, and thus may function as an anchor protein regulating the linkage between VPP and the actin-based cytoskeleton (43). Goldstein et al. (27) demonstrated that hydrophobic intramembrane interactions govern the association of E5, 16-kDa subunit c of VPP, and the platelet-derived growth factor receptor, suggesting a ligand-independent mechanism for receptor activation and a potential link between receptor signal transduction pathways and membrane pore activity. An association of V-ATPase with a calcium-releasing channel and the CIC-5 chloride channel have been defined also (33).

The mechanism of Asbt apical membrane targeting has not been fully established. Previous studies (15) from our laboratory demonstrated that rat Asbt follows an apical sorting pathway that is brefeldin A-sensitive and insensitive to protein glycosylation, monensin treatment, and low temperature shift. Furthermore, a 14-mer signal sequence that adopts a {beta}-turn conformation is required for apical localization of rat Asbt (15). In this study, the VPP-c has been identified as an interacting partner of Asbt. The results shown that the VPP-c interacts with non-glycosylated Asbt.

Bafilomycin treatment caused the accumulation of the Asbt protein largely at perinuclear endoplasmic reticulum-Golgi regions and a decrease in the initial apical taurocholate transport activity in Asbt-transfected cells. Recent studies (33, 44) have identified subunit c as a key part of the binding site for the highly specific V-ATPase inhibitor bafilomycin A. Zhang et al. (4) reported that bafilomycin also binds to a 100-kDa subunit of Vo complexes. There are several possible explanations for these effects of bafilomycin on the Asbt membrane sorting in transfected cells. 1) The 16-kDa subunit c of V-ATPase containing the binding site for the inhibitor bafilomycin may contribute to the directional sorting of Asbt from the Golgi complex to the plasma membrane. 2) It is possible that as a result of bafilomycin binding to the 100-kDa subunit of Vo, the conformations of other Vo subunits including subunit c have been altered. These conformational changes of VPP-c may interfere with the interaction of VPP-c with Asbt and thereby partially interrupt Asbt membrane sorting. 3) Previous studies (4) demonstrated that the Vo domain remains assembled as a 260-kDa complex even after dissociation of the V1 subunits and that the clathrin-coated vesicles contain a significant population of Vo domains not complexed with V1 subunits. The bafilomycin treatment may alter vesicle movement and inhibit trafficking of the transporters to the cell surface. 4) The process of vesicle acidification is also likely to play a role in proper targeting of Asbt to the apical membrane, particularly in the Golgi because the 16-kDa subunit c is associated with the non-glycosylated form of Asbt. However, the effects of V-ATPase on trafficking of Asbt may transcend its properties as a proton pump.

There are a number of yet to be defined steps in which V-ATPase and/or its subunit c of the Vo domain may influence the continuous flow of membranes leading to the correct targeting of Asbt to the apical membrane. In transfected MDCK cells, the Asbt protein partially overlaps with VPP-c and bafilomycin treatment results only in partial interruption of apical membrane localization and initial taurocholate transport activity of Asbt. These results suggest that Asbt apical membrane sorting may involve a VPP-c-mediated pathway and other unknown mechanism(s) in epithelial cells. Multiple apical targeting mechanisms for G-protein-coupled receptors in polarized renal epithelial cells have been reported by Saunders and Limbird (23). Our previous studies show that the cytoplasmic tail of rat Asbt is important for its apical membrane localization. However, in the M2H system, only a slight increase of luciferase activity was observed in the Asbt-tail and VPP-c cotransfected cells. This suggests that the tail of Asbt may only weakly interact with VPP-c and/or the cytoplasmic tail of Asbt alone may not sufficient for binding VPP-c. To understand how the Asbt and VPP-c proteins interact with each other requires further investigation.


   FOOTNOTES
 
* This work was supported in part by the National Institutes of Health Grant HD20632 (to F. J. S.). Confocal laser scanning microscopy was performed at the Mount Sinai School of Medicine-Confocal Laser Scanning Microscopy core facility, supported with funding from the National Institutes of Health Shared Instrumentation Grant 1 S10 RR0 9145-01 and National Science Foundation Major Research Instrumentation Grant DBI-9724504. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ To whom correspondence should be addressed: Dept. of Pediatrics, Box 1664, Mount Sinai Medical School, One Gustave L. Levy Place, New York, NY 10029-6574. Tel.: 212-241-2366; Fax: 212-426-1972; E-mail: An-Qiang.Sun{at}mssm.edu.

1 The abbreviations used are: Asbt, rat apical sodium-dependent bile acid transporter; VPP, vacuolar proton pump; VPP-c, 16-kDa subunit c of vacuolar proton pump; B2H, BacterioMatch two-hybrid; M2H, mammalian two-hybrid; GST, glutathione S-transferase; X-gal, 5-bromo-4-chloro-3-indolyl-{beta}-D-galactopyranoside; PBS, phosphate-buffered saline; BA1, bafilomycin A1; sulfo-NHS-LC-biotin, 6-((biotinoyl)amino)hexanoic acid, sulfosuccinimidyl ester sodium salt; MDCK, Madin-Darby canine kidney. Back



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Karpen, S. J. (2002) J. Hepatol. 36, 832-850[CrossRef][Medline] [Order article via Infotrieve]
  2. Shneider, B. L., Dawson, P. A., Christie, D.-M., Hardikar, W., Wong, M. H., and Suchy, F. J. (1995) J. Clin. Investig. 95, 745-754[Medline] [Order article via Infotrieve]
  3. Montagnani, M., Love, M. W., Rossel, P., Dawson, P. A., and Qvist, P. (2001) Scand. J. Gastroenterol. 36, 1077-1080[CrossRef][Medline] [Order article via Infotrieve]
  4. Zhang, J., Feng, Y., and Forgac, M. (1994) J. Biol. Chem. 269, 23518-23523[Abstract/Free Full Text]
  5. Sun, A.-Q., Ananthanarayanan, M., Soroka, C. J., Thevananther, S., Shneider, B., and Suchy, F. J. (1998) Am. J. Physiol. 275, G1045-G1055[Medline] [Order article via Infotrieve]
  6. Sun, A.-Q., Arresa, M. A., Zeng, L., Swaby, I., Zhou, M. M., and Suchy, F. J. (2001) J. Biol. Chem. 276, 6825-6833[Abstract/Free Full Text]
  7. Liu, C. J., Wang, H., and Lengyel, P. (1999) EMBO J. 18, 2845-2854[CrossRef][Medline] [Order article via Infotrieve]
  8. Lisanti, M. P., Sargiacomo, M., Graeve, L., Saltiel, A. R., and Rodriguez-Boulan, E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 9557-9561[Abstract/Free Full Text]
  9. Altin, J. G., and Pagler, E. B. (1995) Anal. Biochem. 224, 382-389[CrossRef][Medline] [Order article via Infotrieve]
  10. Nezu, J-I., Motojima, K., Tamura, H-O., and Ohkuma, S. (1992) J. Biochem. (Tokyo) 112, 212-219[Abstract/Free Full Text]
  11. Kipp, H., and Arias, I. (2000) Semin. Liver Dis. 20, 339-351[CrossRef][Medline] [Order article via Infotrieve]
  12. Caplan, M. J. (1997) Am. J. Physiol. 272, G1304-G13013[Medline] [Order article via Infotrieve]
  13. Matter, K., and Mellman, I. (1994) Curr. Opin. Cell Biol. 6, 545-554[CrossRef][Medline] [Order article via Infotrieve]
  14. Takeda, T., Yamazaki, H., and Farquhar, M. G. (2003) Am. J. Physiol. 284, C1105-C1113
  15. Sun, A.-Q., Salkar, R., Sachchidanand, Xu, S., Zeng, L., Zhou, M. M., and Suchy, F. J. (2003) J. Biol. Chem. 278, 4000-4009[Abstract/Free Full Text]
  16. Kamal, A., and Goldstein, L. S. (2000) Curr. Opin. Cell Biol. 12, 503-508[CrossRef][Medline] [Order article via Infotrieve]
  17. Matter, K., Bucher, K., and Hauri, H. P. (1990) EMBO J. 9, 3163-3170[Medline] [Order article via Infotrieve]
  18. Riento, K., Kauppi, M., Keranen, S., and Olkkonen, V. M. (2000) J. Biol. Chem. 275, 13476-13483[Abstract/Free Full Text]
  19. Milewski, M. I., Mickle, J. E., Forrest, J. K., Stafford, D. M., Moyer, B. D., Cheng, J., Guggino, W. B., Stanton, B. A., and Cutting, G. R. (2001) J. Cell Sci. 114, 719-726[Abstract]
  20. Short, D. B., Trotter, K. W., Reczek, D., Silvia M., Kreda, S. M., Bretscher, A., Boucher, R. C., Stutts, M. J., and Milgram, S. L. (1998) J. Biol. Chem. 273, 19797-19801[Abstract/Free Full Text]
  21. Waters, M. G., and Pfeffer, S. R. (1999) Cur. Opin. Cell Biol. 11, 453-459[CrossRef][Medline] [Order article via Infotrieve]
  22. Pei, D., Kang, T., and Qi, H. (2000) J. Biol. Chem. 275, 33988-33997[Abstract/Free Full Text]
  23. Saunders, C., and Limbird, L. E. (1997) J. Biol. Chem. 272, 19035-19045[Abstract/Free Full Text]
  24. Nakhoul, N. L, and Hamm, L. L. (2002) J. Nephrol. 15, Suppl. 5, 22-31[Medline] [Order article via Infotrieve]
  25. Forgac M., (2000) J. Exp. Biol. 203, 71-80[Abstract]
  26. Adam, J. L, Briggs, M. W, and McCance, D. J. (2000) Virology 272, 315-325[CrossRef][Medline] [Order article via Infotrieve]
  27. Goldstein, D. J., Andresson, T., Sparkowski, J. J., and Schlegel, R. (1992) EMBO J. 11, 4851-4859[Medline] [Order article via Infotrieve]
  28. Skinner, M. A., and Wildeman, A. G. (1999) J. Biol. Chem. 274, 23119-23127[Abstract/Free Full Text]
  29. Conboy, I. M., Manoli, D., Mhaiskar, V., and Jones, P. P. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 6324-6329[Abstract/Free Full Text]
  30. Maquoi, E., Peyrollier, K., Noel, A., Foidart, J. M., and Frankenne, F. (2003) Biochem. J. 373, 19-24[CrossRef][Medline] [Order article via Infotrieve]
  31. Mandic, R., Fackler, O. T., Geyer, M., Linnemann, T., Zheng, Y. H., and Peterlin, B. M. (2001) Mol. Biol. Cell 12, 463-473[Abstract/Free Full Text]
  32. Sze, H., Ward, J. M., and Lai, S. (1992) J. Bioenerg. Biomembr. 24, 371-381[CrossRef][Medline] [Order article via Infotrieve]
  33. Nishi, T., and Forgac, M. (2002) Nat. Rev. 3, 94-103
  34. van Weert, A. W., Geuze, H. J., and Stoorvogel, W. (1997) Eur. J. Cell Biol. 74, 417-423[Medline] [Order article via Infotrieve]
  35. Yilla, M., Tan, A., Ito, K., Miwa, K., and Ploegh, H. L. (1993) J. Biol. Chem. 268, 19092-19100[Abstract/Free Full Text]
  36. Brown, D., and Breton, S. (2000) J. Exp. Biol. 203, 137-145[Abstract]
  37. Palokangas, H., Ying, M., Vaananen, K., and Saraste, J. (1998) Mol. Biol. Cell. 9, 3561-3578[Abstract/Free Full Text]
  38. Jansen, E. J., Holthuis, J. C., McGrouther, C., Burbach, J. P., and Martens, G. J. (1998) J. Cell Sci. 111, 2999-3006[Abstract]
  39. Geyer, M., Fackler, O. T., and Peterlin, B. M. (2002) Mol. Biol. Cell. 13, 2045-2056[Abstract/Free Full Text]
  40. Geyer, M., Yu, H., Mandic, R., Linnemann, T., Zheng, Y. H., Fackler, O. T., and Peterlin, B. M. (2002) J. Biol. Chem. 277, 28521-28529[Abstract/Free Full Text]
  41. Miura, K., Miyazawa, S., Furuta, S., Mitsushita, J., Kamijo, K., Ishida, H., Miki, T., Suzukawa, K., Resau, J., Copeland, T. D., and Kamata, T. (2001) J. Biol. Chem. 276, 46276-46283[Abstract/Free Full Text]
  42. Koralnik, I. J., Mulloy, J. C., Andresson, T., Fullen, J., and Franchini, G. (1995) J. Gen. Virol. 76, 1909-1916[Abstract/Free Full Text]
  43. Vitavska, O., Wieczorek, H., and Merzendorfer, H. (2003) J. Biol. Chem. 278, 18499-18505[Abstract/Free Full Text]
  44. Bowman, B., and Bowman, E. J. (2002) J. Biol. Chem. 277, 3965-3972[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. Annaba, Z. Sarwar, P. Kumar, S. Saksena, J. R. Turner, P. K. Dudeja, R. K. Gill, and W. A. Alrefai
Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G489 - G497.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A.-Q. Sun, N. Balasubramaniyan, K. Xu, C. J. Liu, V. M. Ponamgi, H. Liu, and F. J. Suchy
Protein-protein interactions and membrane localization of the human organic solute transporter
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1586 - G1593.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A.-Q. Sun, N. Balasubramaniyan, H. Chen, M. Shahid, and F. J. Suchy
Identification of Functionally Relevant Residues of the Rat Ileal Apical Sodium-dependent Bile Acid Cotransporter
J. Biol. Chem., June 16, 2006; 281(24): 16410 - 16418.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/16/16295    most recent
M312838200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, A.-Q.
Right arrow Articles by Suchy, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, A.-Q.
Right arrow Articles by Suchy, F. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics